CTD HOLDINGS ESTABLISHES SECOND CLINICAL TRIAL SITE FOR US PHASE I CLINICAL STUDY OF TRAPPSOL® CYCLO™ FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C OCT 5, 2018, 8 : 00 am edt

Press/Media: Press / Media

PeriodOct 5 2018

Media coverage

2

Media coverage

  • TitleCTD HOLDINGS ESTABLISHES SECOND CLINICAL TRIAL SITE FOR US PHASE I CLINICAL STUDY OF TRAPPSOL® CYCLO™ FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C OCT 5, 2018, 8 : 00 am edt
    Media name/outletMarketScreener.com
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams
  • TitleCTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C Oct 5, 2018, 8:00 AM EDT
    Media name/outletMarketScreener.com
    CountryUnited States
    Date10/5/18
    PersonsDarius Adams